About Thalassaemia

Thalassaemia is one of a group of genetic blood disorders referred to as haemoglopinopathies.

These disorders, mainly comprising different types of thalassaemia and sickle cell anaemia, are among the most common hereditary diseases worldwide: around 7% of the global population carry an abnormal haemoglobin gene, and more than half a million affected children are born each year.

Medical advances in thalassaemia have changed the natural history of the disease, such that it is now both preventable and treatable – a chronic, rather than a fatal, condition. With appropriate clinical management and health care, patients with thalassaemia can lead a near – normal life as integrated, productive members of society.

The treatment of thalassaemia is lifelong, complex and can be costly, requiring specialised expertise and a multi-disciplinary approach. The majority of patients, particularly in low-resource countries are children. This is because, without treatment, patients die at an early age. In addition to the struggle faced by patients coping with the disease, thalassaemia has great emotional, social and financial repercussions for families as a whole.

Information from TIF 2013

  • Extract from About ThalassaemiaPublished by TIF

Alpha Thalassaemia

Carrying alpha thalassaemia does not cause any illness. Most people who carry alpha thalassaemia do not know they have it. They only discover it when they have a special blood test.

Continue reading “Alpha Thalassaemia”


Beta Thalassaemia Major

A carrier of the abnormal gene as in Beta Thal is usually symptomless but where incidences in populations are high the chance of two carriers having a child with Thalassaemia escalates.

Continue reading “Beta Thalassaemia Major”